Goldmet G 1 Tablet PR is a combination oral hypoglycemic agent containing Glimepiride 1 mg and Metformin 500 mg, indicated for the management of type 2 diabetes mellitus, particularly in patients inadequately controlled by diet and exercise alone. Glimepiride, a sulfonylurea, stimulates pancreatic beta-cell insulin secretion, thereby enhancing endogenous insulin levels. Metformin, a biguanide, primarily acts by decreasing hepatic glucose production, improving peripheral glucose uptake, and enhancing insulin sensitivity without causing significant hypoglycemia when used alone. The combination provides complementary mechanisms to achieve better glycemic control. Goldmet G 1 Tablet PR is prescribed as part of a comprehensive diabetes management plan that includes diet modification, exercise, and regular monitoring of blood glucose levels. It is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, severe renal or hepatic impairment, or hypersensitivity to its components. Caution is advised in patients with cardiovascular disease, risk of lactic acidosis, or during radiologic studies involving iodinated contrast agents. Common adverse effects may include gastrointestinal disturbances, hypoglycemia, and weight gain. Regular monitoring of blood glucose, renal function, and liver enzymes is recommended during therapy to ensure safety and efficacy.

Dosage & How to Use